Danna M. Breen

2.4k total citations
36 papers, 1.4k citations indexed

About

Danna M. Breen is a scholar working on Physiology, Surgery and Molecular Biology. According to data from OpenAlex, Danna M. Breen has authored 36 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Physiology, 10 papers in Surgery and 10 papers in Molecular Biology. Recurrent topics in Danna M. Breen's work include Nutrition and Health in Aging (11 papers), GDF15 and Related Biomarkers (9 papers) and Adipose Tissue and Metabolism (7 papers). Danna M. Breen is often cited by papers focused on Nutrition and Health in Aging (11 papers), GDF15 and Related Biomarkers (9 papers) and Adipose Tissue and Metabolism (7 papers). Danna M. Breen collaborates with scholars based in Canada, United States and United Kingdom. Danna M. Breen's co-authors include Tony K.T. Lam, Adria Giacca, Brittany A. Rasmussen, Evangelia Tsiani, Toran Sanli, Andrea Kokorovic, Grace W.C. Cheung, Clémence D. Côté, Rennian Wang and Zhidan Wu and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Danna M. Breen

35 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danna M. Breen Canada 20 785 451 330 267 219 36 1.4k
Jacob Jeppesen Denmark 26 1.2k 1.5× 1.1k 2.5× 395 1.2× 249 0.9× 113 0.5× 36 2.1k
Bruno Pillot France 15 574 0.7× 644 1.4× 502 1.5× 271 1.0× 54 0.2× 36 1.4k
Freyja D. James United States 24 713 0.9× 794 1.8× 425 1.3× 321 1.2× 51 0.2× 45 1.6k
Kim A. Sjøberg Denmark 22 971 1.2× 708 1.6× 162 0.5× 219 0.8× 133 0.6× 36 1.6k
Christophe Noll Canada 21 883 1.1× 293 0.6× 181 0.5× 208 0.8× 153 0.7× 53 1.6k
Kavithalakshmi Sataranatarajan United States 23 524 0.7× 977 2.2× 159 0.5× 109 0.4× 40 0.2× 33 1.6k
Xiaojun Ma China 27 513 0.7× 676 1.5× 126 0.4× 222 0.8× 24 0.1× 63 1.8k
Rocío Guzmán‐Ruiz Spain 17 420 0.5× 351 0.8× 278 0.8× 150 0.6× 53 0.2× 40 1.2k
Farah S. L. Thong Canada 20 590 0.8× 711 1.6× 299 0.9× 220 0.8× 27 0.1× 26 1.7k
Alexandra Chadt Germany 22 568 0.7× 909 2.0× 402 1.2× 187 0.7× 28 0.1× 54 1.5k

Countries citing papers authored by Danna M. Breen

Since Specialization
Citations

This map shows the geographic impact of Danna M. Breen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danna M. Breen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danna M. Breen more than expected).

Fields of papers citing papers by Danna M. Breen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danna M. Breen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danna M. Breen. The network helps show where Danna M. Breen may publish in the future.

Co-authorship network of co-authors of Danna M. Breen

This figure shows the co-authorship network connecting the top 25 collaborators of Danna M. Breen. A scholar is included among the top collaborators of Danna M. Breen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danna M. Breen. Danna M. Breen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Breen, Danna M., Jimmy Kong, J. Brent Kuzmiski, et al.. (2025). Evaluation of leptin treatment on maintenance of body weight loss in diet‐induced obese mice. Diabetes Obesity and Metabolism. 28(1). 401–416.
2.
Groarke, John D., Jeffrey Crawford, Susie M. Collins, et al.. (2024). Phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia: PROACC‐1 study design. Journal of Cachexia Sarcopenia and Muscle. 15(3). 1054–1061. 20 indexed citations
3.
Bonomi, Philip, Sandra L. Gomez‐Perez, Palmi Shah, et al.. (2024). Frequency of weight and body composition increases in advanced non‐small cell lung cancer patients during first line therapy. Journal of Cachexia Sarcopenia and Muscle. 15(6). 2311–2322. 1 indexed citations
4.
Ghidewon, Misgana Y., Aaron D. McKnight, Bart C. De Jonghe, et al.. (2022). Growth differentiation factor 15 ( GDF15 ) and semaglutide inhibit food intake and body weight through largely distinct, additive mechanisms. Diabetes Obesity and Metabolism. 24(6). 1010–1020. 36 indexed citations
5.
Breen, Danna M., Anita Patel, Xiangping Li, et al.. (2021). Growth differentiation factor 15 neutralization does not impact anorexia or survival in lipopolysaccharide-induced inflammation. iScience. 24(6). 102554–102554. 17 indexed citations
6.
Breen, Danna M., Hanna Kim, Donald Bennett, et al.. (2020). GDF-15 Neutralization Alleviates Platinum-Based Chemotherapy-Induced Emesis, Anorexia, and Weight Loss in Mice and Nonhuman Primates. Cell Metabolism. 32(6). 938–950.e6. 115 indexed citations
7.
8.
Guo, June, Troy J. Pereira, Yusaku Mori, et al.. (2020). Resveratrol Inhibits Neointimal Growth after Arterial Injury in High-Fat-Fed Rodents: The Roles of SIRT1 and AMPK. Journal of Vascular Research. 57(6). 325–340. 5 indexed citations
9.
Borner, Tito, Misgana Y. Ghidewon, Bei Zhang, et al.. (2020). GDF15 Induces an Aversive Visceral Malaise State that Drives Anorexia and Weight Loss. Cell Reports. 31(3). 107543–107543. 69 indexed citations
10.
Koulajian, Khajag, et al.. (2019). Pharmacologic or genetic activation of SIRT1 attenuates the fat-induced decrease in beta-cell function in vivo. Nutrition and Diabetes. 9(1). 11–11. 10 indexed citations
11.
Côté, Clémence D., Brittany A. Rasmussen, Frank A. Duca, et al.. (2015). Resveratrol activates duodenal Sirt1 to reverse insulin resistance in rats through a neuronal network. Nature Medicine. 21(5). 498–505. 124 indexed citations
12.
Guo, June, Danna M. Breen, Troy J. Pereira, et al.. (2015). The effect of insulin to decrease neointimal growth after arterial injury is endothelial nitric oxide synthase-dependent. Atherosclerosis. 241(1). 111–120. 18 indexed citations
13.
Rasmussen, Brittany A., Danna M. Breen, Frank A. Duca, et al.. (2014). Jejunal Leptin-PI3K Signaling Lowers Glucose Production. Cell Metabolism. 19(3). 548–548. 1 indexed citations
14.
Pereira, Sandra, Danna M. Breen, Penny Y.T. Wang, et al.. (2014). In vivo effects of polyunsaturated, monounsaturated, and saturated fatty acids on hepatic and peripheral insulin sensitivity. Metabolism. 64(2). 315–322. 23 indexed citations
15.
Rasmussen, Brittany A., Danna M. Breen, Ping Luo, et al.. (2012). Duodenal Activation of cAMP-Dependent Protein Kinase Induces Vagal Afferent Firing and Lowers Glucose Production in Rats. Gastroenterology. 142(4). 834–843.e3. 41 indexed citations
16.
Breen, Danna M., Brittany A. Rasmussen, Andrea Kokorovic, et al.. (2012). Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes. Nature Medicine. 18(6). 950–955. 164 indexed citations
17.
Rasmussen, Brittany A., Danna M. Breen, & Tony K.T. Lam. (2011). Lipid sensing in the gut, brain and liver. Trends in Endocrinology and Metabolism. 23(2). 49–55. 38 indexed citations
18.
Breen, Danna M., et al.. (2010). Insulin Inhibits and Oral Sucrose Increases Neointimal Growth after Arterial Injury in Rats. Journal of Vascular Research. 47(5). 412–422. 9 indexed citations
19.
Breen, Danna M., et al.. (2010). Gut–brain signalling: how lipids can trigger the gut. Diabetes/Metabolism Research and Reviews. 27(2). 113–119. 18 indexed citations
20.
Breen, Danna M., Toran Sanli, Adria Giacca, & Evangelia Tsiani. (2008). Stimulation of muscle cell glucose uptake by resveratrol through sirtuins and AMPK. Biochemical and Biophysical Research Communications. 374(1). 117–122. 183 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacob Jeppesen Breakdown of academic impact, for papers by Bruno Pillot Breakdown of academic impact, for papers by Freyja D. James Breakdown of academic impact, for papers by Kim A. Sjøberg Breakdown of academic impact, for papers by Christophe Noll Breakdown of academic impact, for papers by Kavithalakshmi Sataranatarajan Breakdown of academic impact, for papers by Xiaojun Ma Breakdown of academic impact, for papers by Rocío Guzmán‐Ruiz Breakdown of academic impact, for papers by Farah S. L. Thong Breakdown of academic impact, for papers by Alexandra Chadt
Rankless by CCL
2026